Trial
NCT03179995
Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Major Liver Resection
Intervention
Octreotide
Why stopped
Grantor closed study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-14